Table 1.
Characteristic | LAR (n = 24) | TEM (n = 24) | p |
---|---|---|---|
mean age | 60.7 (40–85) | 59.8 (32–79) | 0.812 |
gender male | 12 (50%) | 12 (50%) | 1 |
ASA 1 | 3 (13%) | 3 (13%) | 1 |
ASA 2 | 19 (79%) | 19 (79%) | 1 |
ASA 3 | 2 (8%) | 2 (8%) | 1 |
mean size * | 3.3 (1–7) | 2.9 (0.04–5.5) | 0.085 |
mean location ** | 10.8 (4–20) | 9.7 (3–16) | 0.323 |
Histopathology | <0.00001 | ||
Adenoma +/− HGD | 3 (12%) | 18 (75%) | |
Adenocarcinoma | 21 (88%) | 6 (25%) | |
Stage 1 | 6 (25%) | 6 (25%) | |
Stage 2 | 5 (21%) | ||
Stage 3 | 10 (42%) |
* largest diameter; ** distal extent of lesion measured from anal verge.